PDS Biotech Raises $5.3M, Adjusts Warrants
Update: 2025-11-11
Description
PDS Biotechs stock dips after announcing a $5.3M stock offering, aiming to fund VERSATILE-zero zero three Phase Three trial and FDA discussions for PDS zero one zero one product.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
